PediaVue Baby Eye Screening

  • Home
  • PediaVue Baby Eye Screening

PediaVue Baby Eye Screening PEDIAVUE also conducts talks and parental programmes to increase public awareness. The measuring principle is based on eccentric photoretinoscopy.

PEDIAVUE™ INTERNATIONAL provides professional support to doctors or optometrists to provide early preventive PediaVue™ Baby Eye Screening services. Babies should check their eyes at 6 - 10months, 15 -18months and 24 - 30 months, or as recommended by your baby's pediatrician. Early detection and intervention is important especially for a baby whose eyes and visual system are still developing. Hence, your baby can be seen by an optometrist or doctor who provides PediaVue™ Baby Eye Screening. The PediaVue Baby Eye Screening consists of a series of baby-specific vision tests by an optometrist and the use of the Pediatric PlusOptix™ vision screening technology to determine if there are any early signs of abnormalities. PediaVue™ Baby Eye Screening utilises the most up-to-date binocular real-time video photorefractive imaging technology from state-of-the-art German medical device manufacturer PlusOptix™ GmbH. Your baby’s eyes will be tested simultaneously to obtain their refractive data, pupil size, gaze deviation and eye misalignment. The screening does not require the use of eye drops and it is quickly done from a safe testing distance of 1 metre. Other benefits include:

- Simultaneously assesses both eyes

- Quick acquisition time: 0.8 seconds

- Safe testing distance: 1 metre

- Non-invasive procedure

- No eye drops required

- FDA approved technology

- Patient Report: Easy to Interpret

www.pediavue.com

24/07/2024

More tests ≠ Better health screening package

If you think a health screening package is better just because it has more tests, think again! An appropriate health screening package should include the tests based on your age, gender, pre-existing condition(s), and date of last health screening.
---
For a customisable and evidence-based health screening appointment with NUH Wellness Centre, visit for.sg/nuh-wellness-centre

28/03/2024
11/01/2024

2024: Great start to a new year! Dr Yap Tiong Peng has joined the Editorial Review Board of the Journal of Optometry and Visual Performance (OVP) - an international journal dedicated to the enhancement and rehabilitation of functional vision (i.e. vision therapy). To date, Dr Yap has completed more than 100 peer reviews with scientific journals throughout the world, including:

- Annals of Eye Science
- Applied Sciences
- BMC Ophthalmology
- BMJ Open
- Children
- Clinical Epidemiology
- Clinical and Experimental Optometry
- Clinical Optometry
- Clinical Ophthalmology
- Eye and Brain
- Healthcare
- Frontiers in Psychology
- Frontiers in Neuroscience
- International Journal of Environmental Research and Public Health
- International Journal of General Medicine
- Journal of Clinical Medicine
- Journal of Neural Transplantation & Plasticity
- Nature Scientific Reports
- Ophthalmology and Eye Diseases
- Pharmacy
- PlosOne
- Therapeutic Advances in Ophthalmology
- Life
- Vision

15/05/2023

Sharing our patient’s story - Vision Therapy by IGARD

15/05/2023
05/09/2021

EXPERTSCAPE PUBLISHES TOP EXPERTS IN AMBLYOPIA TREATMENT (SINGAPORE). Expertscape, a website that identifies and objectively ranks physicians and researchers that excel in the treatment and diagnosis of specific disease states, has released their rankings for Singapore doctors who has expertise in amblyopia treatment. We are very delighted that Dr Yap Tiong Peng (IGARD Vision Therapy) is ranked as the top 2 experts in amblyopia treatment in Singapore (2011 to 2021). Additionally, Dr Yap is ranked #5 in amblyopia and astigmatism in Sydney, Australia (2011 to 2021). Qualified since 1998, Dr Yap is the first and only person in Singapore to be internationally board certified in Vision Therapy and Vision Neurodevelopment. He holds triple clinical fellowships (FAAO, FACBO, FCOVD) and a PhD in children visual development and the electrodiagnosis and treatment of amblyopia. He has expertise in children myopia control, orthokeratology treatment, colorimetry and neurovisual rehabilitation, including low vision, binocular vision (orthoptics) and functional vision. Trained in the UK, US and Australia, Dr Yap graduated from the University of Manchester (UK), Imperial College of Science, Technology and Medicine (UK), University of London (UK) and the University of New South Wales (Australia). He is a Fellow of the American Academy of Optometry and was awarded the David and Diane Goss Fellowship and the Science Communication Training Fellowship from the Association for Research in Vision and Ophthalmology. Check out the Expertscape ranking of the top experts in amblyopia here: https://expertscape.com/ex/amblyopia/c/sg

Thank you to our enthusiastic supporters !!! Please continue to drop in your kid’s preloved glasses in our collection bo...
31/07/2021

Thank you to our enthusiastic supporters !!! Please continue to drop in your kid’s preloved glasses in our collection box before 1st September.

Ask everyone to bring in their *preloved kids glasses* Our donation box is already full but we will start another box tomorrow !!!! This initiative ends on 1st September. Please pass the message around and/or drop by and say hi to Dr Yap & Associates (IGARD Vision Therapy), which is located at 51 Cuppage Road 01-04; opening hours: Monday to Saturday 10:30am-6pm (closed on PH). This is an initiative by Johnson and Johnson and Lions Club International. Find us on: www.IGARD.com.sg

14/04/2021

Congratulations to Dr Yap Tiong Peng (IGARD Group) for being the first and only person in Singapore to be awarded the International Board Certification in Vision Therapy and the Fellowship of the College of Optometrists in Vision Development. He is also the first and only person in Singapore to be awarded the Fellowship of the Australasian College of Behavioural Optometrists and the David and Diane Goss Fellowship of the American Academy of Optometry Foundation.

With Triple Clinical Fellowships (FCOVD, FAAO, FACBO) and a PhD in Optometry, Dr Yap is best known locally for his work on Neurodevelopmental/Behavioural/Functional Vision Therapy and Rehabilitation. He helps children and adults with binocular vision anomalies, visual processing disorders and low vision.

This is a list of Dr Yap’s academic, professional qualifications and credentials:
✅ Clinical Fellow (FACBO, Australia)
✅ Clinical Fellow (FCOVD, USA)
✅ Clinical Fellow (FAAO, USA)
✅ David & Diane Goss Fellow (AAOF, USA)
✅ SCT Fellow (ARVO, USA)
✅ PhD (UNSW Sydney, Australia)
✅ DIC (Imperial College London, UK)
✅ MSc (University of London, UK)
✅ BOptom (Hons) (UMIST Manchester, UK)
✅ OOB Registered (Ministry of Health, Singapore)

Atropine? Orthok? Bifocal? Contact Lenses? Spectacles? —— whichever option you choose for your child’s myopia control, i...
18/11/2019

Atropine? Orthok? Bifocal? Contact Lenses? Spectacles? —— whichever option you choose for your child’s myopia control, it is important to FIRST consider the binocular vision status in relation to those options. Get the eyes checked carefully by an experienced optometrist who does those tests. Don’t just jump straight into it just because your friend or neighbour is doing it 🙂

Practitioners offering myopia management need to know the effect a patient’s binocular vision status has on their management strategies.

21/07/2019

Research Spotlight What’s interesting about children with normal 20/20 visual acuity? That was one of the hot topics at the ARVO Annual Meeting last year and it also received the ARVO Publication Grant this year. The buzzword is “meridional anisotropies” which is the scientific term that descr...

Address


Alerts

Be the first to know and let us send you an email when PediaVue Baby Eye Screening posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

  • Want your practice to be the top-listed Clinic?

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram